CytoSorbents Announces Board Chairman Al W. Kraus To Retire
April 19, 2023 07:00 ET
|
CytoSorbents
PRINCETON, N.J., April 19, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
Landmark Publication Underscores Robust Ability of CytoSorb to Reduce Cytokine Storm during Systemic Hyperinflammation
March 29, 2023 08:30 ET
|
CytoSorbents
PRINCETON, N.J., March 29, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
CytoSorbents Highlights New Clinical Data from Current Studies at the Live 42nd International Symposium on Intensive Care & Emergency Medicine (ISICEM)
March 22, 2023 08:09 ET
|
CytoSorbents
PRINCETON, N.J., March 22, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
Vista Partners Initiates Coverage on CytoSorbents Corporation (OTCQB: CTSO); $0.50 Price Target
January 29, 2014 09:00 ET
|
Vista Partners LLC
SAN FRANCISCO, CA--(Marketwired - Jan 29, 2014) - Vista Partners announced today that it has initiated coverage on CytoSorbents Corporation (OTCQB: CTSO) ("The Company," or "CTSO"); with a twelve...